Advertisement
Online Images in the Medical Sciences| Volume 364, ISSUE 1, e6-e7, July 2022

Shiga toxin-associated hemolytic uremic syndrome

  • Tokio Sasaki
    Affiliations
    Division of Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine, Iwate, Japan

    Department of Internal Medicine, Iwate Prefectural Kuji Hospital, Kuji, Iwate, Japan
    Search for articles by this author
  • Yuji Suzuki
    Correspondence
    Corresponding author at: Division of Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine, 1-1-1 Idaidori, Yahaba-cho, Iwate, 028-3694, Japan.
    Affiliations
    Division of Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine, Iwate, Japan

    Department of Internal Medicine, Iwate Prefectural Kuji Hospital, Kuji, Iwate, Japan
    Search for articles by this author
Published:January 23, 2022DOI:https://doi.org/10.1016/j.amjms.2022.01.006
      A 78-year-old Japanese woman was admitted to our hospital with complaints of right lower abdominal pain and bloody diarrhea. The patient ate undercooked beef 4 days before the onset. Right lower abdominal tenderness was revealed on palpation, and the remaining physical examination was unremarkable. Initial laboratory test results were as follows: white blood cell count 9,000 /µL (normal range 3,300-8,600 /µL), hemoglobin 12.3 g/dL (normal range 11.6-14.8 g/dL), lactate dehydrogenase 288 U/L (normal range 124-222 U/L), and serum creatinine level 1.35 mg/dL (normal range 0.49-0.79 mg/dL). Other laboratory tests, including platelet count and serum biochemistry, were unremarkable. Computed tomography showed a thickened wall of the cecum, ascending colon, and proximal transverse colon (Figure 1A). Colonoscopy revealed marked edema and hemorrhagic mucosa in the cecum and ascending colon (Figure 1B). The stool culture was positive for Shiga toxin-producing Escherichia coli (STEC): O157. Five days following the initiation of supportive therapy, abdominal tenderness and bloody diarrhea resolved. However, laboratory tests showed features of hemolytic uremic syndrome (HUS): thrombocytopenia (platelet count, 43,000 /μL [normal range 158,000-348,000 /μL]), acute kidney injury (creatinine, 1.89 mg/dL), and hemolytic anemia (hemoglobin, 8.6 g/dL; lactate dehydrogenase, 600 U/L; haptoglobin, <10 mg/dL [normal range 66-218 mg/dL]). A peripheral blood smear showed the presence of schistocytes (Fig. 1C, arrows). Shiga toxin-associated HUS (STEC-HUS) was diagnosed. Her urine output decreased to less than 400 mL/day and her serum creatinine increased to 2.5 mg/dL; therefore, she received continuous hemodialysis as renal replacement therapy. After 18 days of hemodialysis, her renal function improved (creatinine 1.02 mg/dL) and she was discharged on hospital day 51.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Majowicz S.E.
        • Scallan E.
        • Jones-Bitton A.
        • et al.
        Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis.
        Foodborne Pathog Dis. 2014; 11: 447-455
        • Kielstein J.T.
        • Beutel G.
        • Fleig S.
        • et al.
        Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
        Nephrol Dial Transplant. 2012; 27: 3807-3815
        • Noris M.
        • Remuzzi G.
        Hemolytic uremic syndrome.
        J Am Soc Nephrol. 2005; 16: 1035-1050